Reaction Details Report a problem with these data
Target
Monoglyceride lipase
Ligand
BDBM521465
Substrate
n/a
Meas. Tech.
In Vitro Competitive Activity-Based Protein Profiling
IC50
<100±n/a nM
Citation
 Grice, CA; Weber, OD; Buzard, DJ; Shaghafi, MB; Wiener, JJ; Cisar, JS; Duncan, KK Pyrazole MAGL inhibitors US Patent  US11149037 Publication Date 10/19/2021 
Target
Name:
Monoglyceride lipase
Synonyms:
HU-K5 | Lysophospholipase homolog | Lysophospholipase-like | MAGL | MGL | MGLL | MGLL_HUMAN
Type:
Hydrolase
Mol. Mass.:
33264.56
Organism:
Homo sapiens (Human)
Description:
Human recombinant MGL (Cayman Chemical, cat# 10008354).
Residue:
303
Sequence:
MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP
  
Inhibitor
Name:
BDBM521465
Synonyms:
N-(1-((2R)-2- Methyl-4-(3- (tetrahydro- 1H-furo [3,4-c]pyrrol- 5(3H)-yl)-4- (trifluoromethyl) benzyl) piperazine- 1-carbonyl)- 1H-pyrazol-3- | US11149037, Example 180
Type:
Small organic molecule
Emp. Form.:
C24H31F3N6O4S
Mol. Mass.:
556.601
SMILES:
C[C@@H]1CN(Cc2ccc(c(c2)N2CC3COCC3C2)C(F)(F)F)CCN1C(=O)n1ccc(NS(C)(=O)=O)n1 |r|
Structure:
Search PDB for entries with ligand similarity: